SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing a sharp stock decline, sparking widespread investor confusion despite recent financial reports indicating better-than-expected performance. The immediate catalyst appears to be market apprehension regarding the debt impact of its substantial acquisition ambitions and a temporary halt in share buybacks. This has divided the community, with many seizing what they call a 'generational' buying opportunity, while others foresee deeper corrections due to perceived growth moderation and sector competition.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending as a "permissionless brandcoin" captivating the crypto space with its continuous development of real-world products, such as KENDU SPICE and energy drinks, available across multiple blockchains. The highly active and bullish community drives its growth, emphasizing a long-term vision and relentless IRL efforts that set it apart from typical hype-driven projects. This unique blend of tangible utility and strong collective conviction makes KENDU a standout topic among enthusiasts.

Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. It operates through the following geographical segments: United States, Germany, Australia, Switzerland, and Sweden. The company was founded in 1999 and is headquartered in Eagan, MN.

Anteris Technologies Global Corp.

Anteris Technologies Global

Anteris Technologies (AVR) is trending due to a strategic private placement by Medtronic complementing a recent public offering, sparking significant community speculation about potential future upside and acquisition. This excitement is further fueled by the company's recent commencement of its pivotal DurAVR heart valve trial, with many viewing the stock as currently undervalued.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals (CRVS) is trending following its announcement of strong Phase 1 clinical trial data for soquelitinib in atopic dermatitis, showcasing high efficacy and a favorable safety profile that excites investors about its blockbuster potential. While the positive results have fueled significant bullish sentiment and speculation around partnerships, a recently announced public offering has simultaneously introduced dilution concerns, leading to mixed community perspectives.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending amid key strategic announcements, including a significant expansion with HD Hyundai in South Korea and a role in building next-gen AI infrastructure across EMEA. CEO Alex Karp's prominent presence at Davos, highlighting AI-driven efficiency and impact, fuels a strong bullish narrative among some investors. Conversely, the community remains divided on its lofty valuation, with others anticipating pullbacks and monitoring broader market volatility.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing a notable surge, primarily fueled by promising 5-year clinical data for its personalized cancer vaccine in collaboration with Merck and recent global regulatory submissions for its seasonal flu vaccine. The community is actively discussing the company's improved financial outlook and strategic shift towards its diverse mRNA pipeline beyond prior vaccine products. This reevaluation is amplified by a significant short interest, with many anticipating continued momentum in the broader biotech sector.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix Corp is trending amidst mixed community reactions to recent developments, including the departure of its COO and announcements of partnerships with smart eyewear companies Jorjin and L'Attitude 52N at CES. While bulls point to independent testing validating high volumetric energy density for its AI-1 battery and long-term potential in AI-driven devices, many investors express frustration over continued delays in securing significant smartphone orders and perceived inconsistencies in management's execution. The conversation highlights a divide between confidence in the company's patented silicon-anode battery technology and skepticism regarding its ability to achieve mass commercialization.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing heightened trading activity as the community awaits the anticipated finalization of the TikTok U.S. deal while simultaneously reacting to news of a bondholder lawsuit citing undisclosed AI infrastructure debt. Investors are sharply divided, debating whether Oracle's extensive cloud and AI investments will propel future growth or if its increasing debt burden makes it a significant risk.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to CEO Diane Garrett's recent FoxTV interview, continuous share accumulation by billionaire investor Eric Sprott, and promising high-grade silver drill results, all against a backdrop of surging silver prices. The community is actively discussing massive upside potential and a potential short squeeze, fueled by Sprott's buying and the company's vast untapped resources. Conversely, a vocal skeptical faction highlights the lack of active mining, dilution risks, and perceived overvaluation, warning of an eventual market correction.

Bit Origin Ltd. operates as an emerging growth company which engages in crypto mining business. The firm also actively deploys blockchain technologies, alongside diversified expansion strategies. It has operations in the United States, Canada, and China. The company was founded on January 23, 2018 and is headquartered in Singapore.

Bit Origin Ltd - Ordinary Shares - Class A

Bit Origin Ltd

Bit Origin Ltd. is trending amid an impending 1-for-60 reverse stock split, a move widely discussed as necessary for regaining NASDAQ compliance. Community sentiment is mixed, with some anticipating a post-split surge while others are wary of further volatility. The company's substantial Dogecoin treasury also keeps it a focus for those tracking broader cryptocurrency market movements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ALX Oncology Spotlights Evorpacept HER2 Strategy and EGFR ADC ALX2004 Progress at JPM Conference

ALX Oncology (NASDAQ:ALXO) outlined progress across its two clinical-stage programs CD47 blocker evorpacept and EGFR-targeted antibody-drug conjugate (ADC) ALX2004 during a presentation at the J.P...

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of "Moderate Buy" by Brokerages

ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the company, Marketbeat...

Short Interest in ALX Oncology Holdings Inc. (NASDAQ:ALXO) Expands By 32.0%

ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) saw a large growth in short interest during the month of December. As of December 15th, there was short interest totaling 1,047,613 shares...

ALX Oncology (NASDAQ:ALXO) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised shares of ALX Oncology from a "sell" rating to a "hold" rating in a research report on Monday...

ALX Oncology (NASDAQ:ALXO) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen downgraded shares of ALX Oncology from a "hold" rating to a "sell" rating in a research report on Sunday...

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Rating of "Moderate Buy" from Analysts

ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) has received an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, MarketBeat.com...

ALX Oncology (NASDAQ:ALXO) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded ALX Oncology from a "sell" rating to a "hold" rating in a report on Saturday...

ALX Oncology (NASDAQ:ALXO) Stock Price Up 3.8% - Here's Why

ALX Oncology (NASDAQ:ALXO) Trading 3.8% Higher - Still a Buy...

ALX Oncology (NASDAQ:ALXO) Earns Buy Rating from Analysts at Jefferies Financial Group

Jefferies Financial Group initiated coverage on ALX Oncology in a research report on Thursday. They set a "buy" rating and a $4.00 target price for the company...

Cantor Fitzgerald Weighs in on ALX Oncology FY2025 Earnings

ALX Oncology Holdings Inc. (NASDAQ:ALXO - Free Report) - Analysts at Cantor Fitzgerald dropped their FY2025 earnings per share estimates for ALX Oncology in a report issued on Monday, November 10th...

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.

Alx Oncology Holdings Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

ALXO
Alx Oncology Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ALXO News

ALXOAlx Oncology Holdings Inc